On Thursday, August 27, 2020, the Alliance for Aging Research submitted comments to the Centers for Disease Control and Prevention (CDC) regarding its Advisory Committee on Immunization Practices (ACIP) and ACIP’s important work in developing recommendations and guidance on the use of vaccines. In the comment letter, the Alliance advocates for ACIP to:
- State a preference for high-dose and adjuvanted flu vaccine over standard-dose vaccine for older adults
- Add more experts in geriatrics and older adult vaccination to the committee
- Eliminate the use of economic considerations that discriminate against older adults and individuals with disabilities
Alliance Vice President of Health Education and Advocacy Lindsay Clarke presented these comments in person to the Committee on Wednesday, August 26.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org